Europe CBD Expo

Start:
Jul 12, 2019, 9:00 AM
End:
Jul 13, 2019, 6:00 PM
Venue:
ExCeL London

About Europe CBD Expo

Located at the home of world leading events ExCeL London, UK, this 2-day hybrid business and consumer trade show and conference dedicated entirely to CBD (Cannabidiol) will feature more than 80 exhibitors, a CBD Link Educational and Networking Area. Attendees will have the opportunity to participate in panel discussions from experts in the research, development, and distribution of CBD products, network, help remove stigma surrounding the industry and grow businesses.

Features


4

WORKSHOPS

30

SPEAKERS +

81

EXHIBITORS

100

PRESS & INFLUENCERS

Speakers

JOANNA WEAVER-PéLISSIER
CHIEF EXECUTIVE OFFICER Be Cann France
Ram Reifen
DIRECTOR THE SCHOOL OF NUTRITIONAL SCIENCES THE HEBREW UNIVERSITY OF JERUSALEM
George McBride
Hannah Deacon
PATIENT ADVOCACY SPECIALIST
Mark Tallon
MANAGING PARTNER & FOUNDER, LEGAL FOODS
Sal Noble
CEO, LONDON CBD GROUP
View More (26)
Basia Zieniewicz
CO-FOUNDER, FAMILIES 4 ACCESS
Richard Hodgson
LC TECHNICAL SPECIALIST, SHIMADZU
Eveline Van Keymeulen
COUNSEL, ALLEN & OVERY
Tamara LahTurnšek
SCIENTIFIC COUNCILLOR, NATIONAL INSTITUTE OF BIOLOGY, SLOVENIA, RESEARCH ON CANNABIS IN CANCER
Dan McMillan
MANAGER, SCIEX
ZOHAR KOREN
Michael Barnes
CLINICAL DIRECTOR
Carly Barton
Deputy Director at United Patients Alliance Ltd
Ehud Olmert
https://www.europecbdexpo.co.uk/wp-content/uploads/2019/04/Ehud-Olmert.jpg
Michael Patterson
CEO, US CANNABIS PHARMA
Alex Fraser
PATIENT ACCESS SPECIALIST, GROW BIOTECH
Alfredo Pascual
International Analyst Marijuana Business Daily
Monica Vialpando
CBD FORMULATION AND PRODUCT DEVELOPMENT STRATEGIES VIALPANDO
Tim Phillips
MANAGING DIRECTOR cbd intel
Dani Gordon
DOCTOR'S GUIDE TO CBD & CANNABINOIDS FOR EVERYONE
JASMIN THOMAS
Founder OHANA CBD
Zeid Mohamedali
CHIEF MEDICAL OFFICER Zenabis Global Inc.
Saoirse O'Sullivan
Associate Professor at University of Nottingham
Patrick Morton
Сo-founder of Cannabis Invest UK
Golan Bitton
CEO
Mark Taylor
JOURNALIST
Irit Avisar
Chairperson at Israeli Medical Cannabis Nursing Association
Costas Vamvakas
MEDICAL CANNABIS INVESTMENT IN GREECE, PANEL, MANAGING DIRECTOR, VK PREMIUM
Mikael Sodergren
Research Director at EMMAC Life Sciences

Sponsors

Gencanna
ICC International Cannabis Corp.
Ignite
UNIVO
BORN CANNABIDIOL CO

Partners

cbd intel
Strain Insider
The Cannabis Reporter
Marijuana Business Magazine
Analytical Cannabis
Cannabis Therapy Magazine
Vapouround CBD
The Hemp Club
View More (3)

Agenda

July 12

09:30 – 10:00
Awaiting Confirmation

10:00 – 10:30
SESSION 1 – Cannabis Regulatory Intelligence
Medical Cannabis and CBD Products in the UK – Quality, Responsibility, Transparency.
MAIN STAGE
Blair Gibbs
Policy Lead, Centre for Medicinal Cannabis (CMC)

10:30 – 11:00
SESSION 1 – Cannabis Regulatory Intelligence
The European regulatory framework for CBD and appetite amongst European regulators and the banking sector to provide support to the industry
MAIN STAGE
Mark Taylor
Compliance and Regulatory Journalist

11:00 – 11:30
SESSION 1 – Cannabis Regulatory Intelligence
Israel Regulatory Standards Vs European Standards
MAIN STAGE
Golan Bitton
CEO, Univo Pharmaceuticals

11:30 – 12:00
COFFEE BREAK

12:00 – 12:30
SESSION 1 – Cannabis Regulatory Intelligence
Regulatory and Market Intelligence for the CBD Sector
MAIN STAGE
Tim Phillips
Managing Director, CBD Intel

12:30 – 13:15
Panel Discussion
European Regulations, Insights & Opportunities – Where are we now? The Future of Cannabis and CBD
Chaired by Karina Lahnakoski
VP of Quality & Regulatory, Cannabis Compliance Inc.
George McBrid
CEО, Hanway Associates
Housam Nasr
COO, London Canna Group
Eveline Van Keymeule
Counsel, Allen & Overy
Blair Gibbs
Policy Lead, Centre for Medicinal Cannabis (CMC)
Hassan Akhtar
Managing Director, CBD Capital

13:15 – 13:45
KEYNOTE SPEAKER
Awaiting Confirmation

13:45 – 14:15
SESSION 2 – Cannabinoid Development Strategies
Investing in Cannabinoids, cultivation, product development, branding and distribution
MAIN STAGE

Patrick Morton
Co-Founder, Cannabis Invest UK

14:15 – 14:45
SESSION 2 – Cannabinoid Development Strategies
Making CBD, Cannabinoids and Medicinal Cannabis affordable: How Emerging Markets will disrupt the global supply chain
MAIN STAGE
Oliver Zugel
Founder and CEO, Foliumed

14:45 – 15:15
SESSION 2 – Cannabinoid Development Strategies
CBD, Cannabinoids and Medicinal Cannabis Formulation & Product Development Strategies
MAIN STAGE
Dr Monica Vialpando
Founder, Vialpando LLC

15:15 – 15:45
SESSION 2 – Cannabinoid Development Strategies
Awaiting Talk Title
MAIN STAGE
Josh Crossney
CEO, Cannabis Science Conference

15:45 – 16:15
SESSION 3 – The Necessity of Cannabis Testing
Awaiting Talk Title
MAIN STAGE
Tracy Szerszon
President, Perry Johnson Lab Accreditation Inc

16:15 – 16:45
SESSION 3 – The Necessity of Cannabis Testing
Determination of CBD and General Cannabinoid Content in Hemp Oils
MAIN STAGE
Dr Richard Hodgson
LC Technical Specialist, Shimadzu

16:45 – 17:15
SESSION 3 – The Necessity of Cannabis Testing
Optimizing Cannabis Testing with Mass Spectrometry
MAIN STAGE
Daniel McMillan
Sr. Manager, SCIEX

17:15 – 17:55
Panel Discussion
Emerging Markets and International Trends – International Insights, Opportunities and Investment
MAIN STAGE
Chaired by Stephen Murphy
CEO, Prohibition Partners
Michael Patterson
CEO, US Cannabis Pharmaceutical Research and Development LLC (USA)
Golan Bitton
CEO, Univo Pharmaceuticals (Israel)
Oliver Zugel
Founder and CEO, Foliumed (Columbia)
Costas Vamvakas
Managing Director, VK PREMIUM Business Consultants Ltd. (Greece)
Mait Soosalu
Advance Biotech Laboratories (Sweden AB)

18:00 – 19:30
Drinks Reception
Evening Entertainment
MAIN HALL & NETWORK AREAS
Band
The What if Generation

July 13

10:00 – 10:30

KEYNOTE

Dr. Zeid Mohamedali
Chief Medical Officer, Zenabis

10:30 – 11:00

SESSION 1 – A Guide to CBD, Cannabinoids and Medical Cannabis
CBD & Cannabinoids for Everyone
MAIN STAGE

Dr Dani Gordon
Doctor, Author, ABIHM, ABIOM

11:00 – 11:30

SESSION 1 – A Guide to CBD, Cannabinoids and Medical Cannabis
Awaiting Talk Title
MAIN STAGE

Prof. Ram Reifen
Director, the Research Centre for Nutrigenomics and Functional Foods, Hebrew University of Jerusalem

11:30 – 12:00

SESSION 1 – A Guide to CBD, Cannabinoids and Medical Cannabis
Pure CBD Vs Whole Plant Preparations
MAIN STAGE

Gregor Zorn
Director and Co-Founder, ECTA, European Cannabinoid Therapy Association

12:00 – 12:30

SESSION 2 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Concepts, Misconceptions & Evidence
Medical Cannabis – From bench to bedside
MAIN STAGE

Mikael Sodergren
Clinical Lecturer in Surgery, Imperial College London

12:30 – 13:00

SESSION 2 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Concepts, Misconceptions & Evidence
Haemodynamic effects of Cannabidiol in humans
MAIN STAGE

Dr Saoirse O’sullivan
Professor, University of Nottingham

13:00 – 13:30

SESSION 2 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Concepts, Misconceptions & Evidence
Research on Cannabis in Cancer
MAIN STAGE

Prof Dr Tamara Lah
Counselor to the Director National Institute of Biology, Slovenia

13:30 – 14:00

KEYNOTE

Prof. Mike Barnes
Chief Medical Officer, European Cannabis Holdings (ECH)

14:00 – 14:45

Panel Discussion
Medical Cannabis Access and Patient Care

Chaired by Prof. Mike Barnes
Chief Medical Officer, ECH, European Cannabis Holdings

Basia Zieniewicz
Co-Founder, Families 4 Access

Hannah Deacon
Patient Advocate, End Our Pain

Irit Avisar
Chairperson, Israeli Medical Cannabis Nurses Association

Carly Barton
Patient Advocate, United Patients Alliance

14:45 – 15:15

SESSION 3 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
Awaiting Talk Title
MAIN STAGE

Irit Avisar
Chairperson, Israeli Medical Cannabis Nurses Association

15:15 – 15:45

SESSION 3 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
Novel synergistic cannabinoid combinations for the treatment of IBS and IBD patients
MAIN STAGE

Zohar Koren Phd
CEO, SciCann Therapeutics Inc.

15:45 – 16:15

SESSION 3 – Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
Pre-Clinical/Clinical Studies of Cannabis & Cannabinoids: Patient Care
MAIN STAGE

Alex Fraser
Patient Access Specialist, Grow Biotech

16:15 – 17:00

Panel Discussion
Women – The Future of Cannabis
MAIN STAGE

Chaired by Kristina Spionjak
Marketing Director, London Canna Group

Dr Dani Gordon
Doctor, Author, ABIHM, ABIOM

Dr Saoirse O’sullivan
Professor, University of Nottingham

Jasmin Thomas
Founder, Ohana CBD

Joanna Weaver-Pélissier
CEO, BeCann

Róisín Delaney
Editor, Vapouround CBD

Dr Monica Vialpando
Founder, Vialpando LLC

17:00 – 17:30

Celebrity Event Closing Giveaway
Ignite CBD Prize Giveaways

Dan Bilzerian